A detailed history of Alaska Permanent Fund Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 66,245 shares of ABBV stock, worth $12.8 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
66,245
Previous 70,497 6.03%
Holding current value
$12.8 Million
Previous $12.8 Million 11.49%
% of portfolio
0.18%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $658,167 - $768,591
-4,252 Reduced 6.03%
66,245 $11.4 Million
Q1 2024

Apr 09, 2024

SELL
$159.82 - $182.1 $207,286 - $236,183
-1,297 Reduced 1.81%
70,497 $12.8 Million
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $70,313 - $79,189
511 Added 0.72%
71,794 $11.1 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $19,637 - $22,733
-147 Reduced 0.21%
71,283 $10.6 Million
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $3.3 Million - $4.11 Million
24,908 Added 53.54%
71,430 $9.62 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $32,364 - $38,813
-234 Reduced 0.5%
46,522 $7.52 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $2.15 Million - $2.47 Million
16,037 Added 52.21%
46,756 $6.28 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $978,753 - $1.24 Million
7,112 Added 30.13%
30,719 $4.71 Million
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $25,868 - $32,095
196 Added 0.84%
23,607 $3.83 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $87,125 - $110,239
811 Added 3.59%
23,411 $3.21 Million
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $263,025 - $293,025
-2,500 Reduced 9.96%
22,600 $2.55 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $670,355 - $786,776
7,803 Added 45.11%
25,100 $2.2 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $347,553 - $465,078
4,737 Added 37.71%
17,297 $1.7 Million
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $810,120 - $1.23 Million
12,560 New
12,560 $957,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.